Growth Metrics

Merck (MRK) FCF Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,649.00
Dec 31, 2025 -695.00
Sep 30, 2025 2,785.00
Jun 30, 2025 156.00
Mar 31, 2025 986.00
Dec 31, 2024 3,525.00
Sep 30, 2024 2,472.00
Jun 30, 2024 1,050.00
Mar 31, 2024 728.00
Dec 31, 2023 -2,929.00
Sep 30, 2023 2,287.00
Jun 30, 2023 -853.00
Mar 31, 2023 -473.00
Dec 31, 2022 -794.00
Sep 30, 2022 4,553.00
Jun 30, 2022 -770.00
Mar 31, 2022 2,432.00
Dec 31, 2021 -171.00
Sep 30, 2021 324.00
Jun 30, 2021 -364.00
Mar 31, 2021 -1,885.00
Dec 31, 2020 -1,866.00
Sep 30, 2020 -1,802.00
Jun 30, 2020 -1,035.00
Mar 31, 2020 -2,439.00
Dec 31, 2019 -461.00
Sep 30, 2019 -1,180.00
Jun 30, 2019 116.00
Mar 31, 2019 -1,415.00
Dec 31, 2018 127.00
Sep 30, 2018 -1,275.00
Jun 30, 2018 926.00
Mar 31, 2018 -1,162.00
Dec 31, 2017 2,288.00
Sep 30, 2017 -3,933.00
Jun 30, 2017 923.00
Mar 31, 2017 -1,610.00
Dec 31, 2016 907.00
Sep 30, 2016 -1,017.00
Jun 30, 2016 -802.00
Mar 31, 2016 828.00
Dec 31, 2015 1,293.00
Sep 30, 2015 947.00
Jun 30, 2015 -154.00
Mar 31, 2015 1,312.00
Dec 31, 2014 -3,124.00
Sep 30, 2014 4,833.00
Jun 30, 2014 1,191.00
Mar 31, 2014 1,214.00